REQUEST A DEMO
Total
USD $0.00
Search more companies

Oxygenta Pharmaceutical Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Oxygenta Pharmaceutical Ltd. Profile Updated: November 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

S S Organics Ltd. is engaged in manufacture of bulk drugs such as quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs are manufactured. The product range also includes omeprazole, rabeprazole sodium, lansoprazole, esomeprazole magnesium trihydrate, non-pariel seeds, pantoprazole pellets, diclofenac sodium pellets, gabapentior, mooxafloxacin, ramipril, atorvastatin, and voriconazole. The company has asubsidiary based in Maryland, USA. S S Organics Ltd. was incorporated in 1990 as a private limited company and was converted into a public limited company in 1993. The registered office of the company is located in Medak.

Legal Address
Survey. No. 252/1,, , Aroor Village
Medak; Telangana; Postal Code: 502291

Contact Details: Purchase the Oxygenta Pharmaceutical Ltd. report to view the information.

Website: http://www.oxygentapharma.com

Basic Information
Total Employees:
Purchase the Oxygenta Pharmaceutical Ltd. report to view the information.
Outstanding Shares:
Purchase the Oxygenta Pharmaceutical Ltd. report to view the information.
Registered Capital:
Purchase the Oxygenta Pharmaceutical Ltd. report to view the information.
Financial Auditors:
Purchase the Oxygenta Pharmaceutical Ltd. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
53.28%
Purchase this report to view the information.
41.81%
Purchase this report to view the information.
4.89%
Purchase this report to view the information.
0.03%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Oxygenta Pharmaceutical Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
83.86%
Total operating revenue
83.86%
Operating profit (EBIT)
43.02%
EBITDA
51.04%
Net Profit (Loss) for the Period
70.17%
Operating Profit Margin (ROS)
42.87%
Net Profit Margin
55.64%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?